Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of etanercept

被引:0
|
作者
Llinares-Tello, Francisca [1 ]
Rosas-Gomez de Salazar, Jose [2 ]
Miguel Senabre-Gallego, Jose [2 ]
Santos-Soler, Gregorio [2 ]
Santos-Ramirez, Carlos [4 ]
Salas-Heredia, Esteban [2 ]
Molina-Garcia, Juan [3 ]
机构
[1] Marina Baixa Hosp, Dept Lab, Alicante 03570, Spain
[2] Marina Baixa Hosp, Dept Rheumatol, Alicante, Spain
[3] Marina Baixa Hosp, Dept Lab, Alicante, Spain
[4] Marina Salud Hosp, Dept Rheumatol, Alicante, Spain
关键词
ELISA; etanercept; therapeutic drug monitoring; COMMERCIALLY AVAILABLE METHODS; RHEUMATOID-ARTHRITIS; ADALIMUMAB; INFLIXIMAB;
D O I
10.1515/cclm-2014-0898
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:E279 / E282
页数:4
相关论文
共 50 条
  • [41] EFFICIENCY OF FLUORESCENCE-POLARIZATION IMMUNOASSAY AND ENZYME-IMMUNOASSAY IN THERAPEUTIC DRUG-MONITORING
    BOGOVSKY, BP
    BARMANOVA, EY
    VOPROSY MEDITSINSKOI KHIMII, 1991, 37 (03): : 80 - 82
  • [42] Design of a surface plasmon resonance immunoassay for therapeutic drug monitoring of amikacin
    Losoya-Leal, Adrian
    Estevez, M. -Carmen
    Martinez-Chapa, Sergio O.
    Lechuga, Laura M.
    TALANTA, 2015, 141 : 253 - 258
  • [43] Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
    Hertz, Daniel L.
    Joerger, Markus
    Bang, Yung-Jue
    Mathijssen, Ron H.
    Zhou, Caicun
    Zhang, Li
    Gandara, David
    Stahl, Michael
    Monk, Bradley J.
    Jaehde, Ulrich
    Beumer, Jan H.
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [44] THERAPEUTIC DRUG-MONITORING BY FLUORESCENCE POLARIZATION - PERFORMANCE OF AN IMMUNOASSAY FOR NETILMICIN
    VANKAMPEN, LJ
    FAMULARE, AJ
    WORTHY, TE
    CLINICAL CHEMISTRY, 1984, 30 (06) : 1027 - 1028
  • [45] Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring
    Kozo, Daniel
    Ross, Matt W.
    Jarrah, Justin
    Barrett, Michael
    Harney, Rebecca L.
    Courtney, Jodi B.
    Baburina, Irina
    Holleran, Julianne L.
    Beumer, Jan H.
    Peters, Godefridus J.
    Honeywell, Richard J.
    Salamone, Salvatore J.
    THERAPEUTIC DRUG MONITORING, 2017, 39 (03) : 235 - 242
  • [46] THERAPEUTIC DRUG MONITORING OF DILANTIN (PHENYTOIN) UTILIZING NEPHELOMETRIC INHIBITION IMMUNOASSAY
    PRANIS, R
    STENGLEIN, K
    KERAN, E
    CLINICAL CHEMISTRY, 1979, 25 (06) : 1095 - 1095
  • [47] Therapeutic Drug Monitoring of Levetiracetam: Comparison of a Novel Immunoassay With an HPLC Method
    Bianchi, Vincenza
    Arfini, Carlo
    Vidali, Matteo
    THERAPEUTIC DRUG MONITORING, 2014, 36 (05) : 681 - 685
  • [48] Therapeutic drug monitoring of voriconazole and posaconazole: analytical and clinical validation of a UPLC-based method
    Verfaillie, C.
    Drieghe, S.
    van den Abeele, A. M.
    Ghys, T.
    MYCOSES, 2011, 54 : 60 - 60
  • [49] Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine
    Posocco, Bianca
    Buzzo, Mauro
    Giodini, Luciana
    Crotti, Sara
    D'Aronco, Sara
    Traldi, Pietro
    Agostini, Marco
    Marangon, Elena
    Toffoli, Giuseppe
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 160 : 360 - 367
  • [50] Amikacin therapeutic drug monitoring: Evaluation of therapy performance and analytical techniques in a developing country setting
    Steffens, Nadine Arnold
    Petreceli, Rodrigo Redel
    Azevedo, Victor Coden
    Franca, Adriana Streher
    Hahn, Roberta Zilles
    Bondan, Amanda Pacheco
    Linden, Rafael
    Charao, Mariele Feiffer
    Schwarzbold, Alexandre de Vargas
    Brucker, Natalia
    CLINICAL BIOCHEMISTRY, 2025, 136